253 related articles for article (PubMed ID: 23039620)
1. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.
Donovan EM; James H; Bonora M; Yarnold JR; Evans PM
Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620
[TBL] [Abstract][Full Text] [Related]
2. Long-term risks of secondary cancer for various whole and partial breast irradiation techniques.
Hoekstra N; Fleury E; Merino Lara TR; van der Baan P; Bahnerth A; Struik G; Hoogeman M; Pignol JP
Radiother Oncol; 2018 Sep; 128(3):428-433. PubMed ID: 29914648
[TBL] [Abstract][Full Text] [Related]
3. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
4. Risk estimation of second primary cancers after breast radiotherapy.
Santos AM; Marcu LG; Wong CM; Bezak E
Acta Oncol; 2016 Nov; 55(11):1331-1337. PubMed ID: 27379458
[TBL] [Abstract][Full Text] [Related]
5. Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy.
Kim DW; Chung WK; Yoon M
Health Phys; 2013 May; 104(5):499-503. PubMed ID: 23532078
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of reducing target volume margins in breast tangent radiotherapy.
Basaula D; Quinn A; Walker A; Batumalai V; Kumar S; Delaney GP; Holloway L
Australas Phys Eng Sci Med; 2017 Jun; 40(2):305-315. PubMed ID: 28243923
[TBL] [Abstract][Full Text] [Related]
7. Estimation of effective imaging dose and excess absolute risk of secondary cancer incidence for four-dimensional cone-beam computed tomography acquisition.
Yuasa Y; Shiinoki T; Onizuka R; Fujimoto K
J Appl Clin Med Phys; 2019 Nov; 20(11):57-68. PubMed ID: 31593377
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
9. An investigation of image guidance dose for breast radiotherapy.
Alvarado R; Booth JT; Bromley RM; Gustafsson HB
J Appl Clin Med Phys; 2013 May; 14(3):4085. PubMed ID: 23652243
[TBL] [Abstract][Full Text] [Related]
10. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
11. Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy - A model for out-of-field organs of paediatric patients with cranial cancer.
Dell'Oro M; Short M; Wilson P; Peukert D; Hua CH; Merchant TE; Bezak E
Radiother Oncol; 2022 Jul; 172():65-75. PubMed ID: 35504365
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of radiation dose delivered by cone beam CT and tomosynthesis employed for setup of external breast irradiation.
Winey B; Zygmanski P; Lyatskaya Y
Med Phys; 2009 Jan; 36(1):164-73. PubMed ID: 19235385
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculation of imaging doses from diagnostic multidetector CT and kilovoltage cone-beam CT as part of prostate cancer treatment plans.
Ding A; Gu J; Trofimov AV; Xu XG
Med Phys; 2010 Dec; 37(12):6199-204. PubMed ID: 21302776
[TBL] [Abstract][Full Text] [Related]
14. Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery.
Xie Y; Bourgeois D; Guo B; Zhang R
Med Dosim; 2020 Winter; 45(4):e9-e16. PubMed ID: 32646715
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
16. Partial kilovoltage cone beam computed tomography, complete kilovoltage cone beam computed tomography, and electronic portal images for breast radiation therapy: A dose-comparison study.
Bahig H; Roussin É; Yassa M; Vavassis P; Lemaire C; Archambault L; Nguyen DHA
Pract Radiat Oncol; 2015; 5(5):e521-e529. PubMed ID: 25823380
[TBL] [Abstract][Full Text] [Related]
17. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer.
Santos AMC; Kotsanis A; Cunningham L; Penfold SN
Acta Oncol; 2021 Mar; 60(3):300-304. PubMed ID: 33345660
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in a patient with left breast cancer and pectus excavatum.
Cendales R; Vasquez J; Arbelaez JC; Bobadilla I; Espanol R; Torres F; Gaitan A
Clin Transl Oncol; 2012 Oct; 14(10):747-54. PubMed ID: 22855154
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
20. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
